Oragenics, Inc. (NYSE:OGEN) went up by 15.89% from its latest closing price when compared to the 1-year high value of $3.74 and move down -580%, while OGEN stocks collected +12.41% of gains with the last five trading sessions.
Oragenics, Inc. (NYSE:OGEN) Worth an Investment?
Oragenics, Inc. (NYSE: OGEN) The 36 Months beta value for OGEN stocks is at 1.53, while 2 of the analysts out of 2 who provided ratings for Oragenics, Inc. stocks as a “buy” while 0 as overweight, 0 rated it as hold and 0 as sell. The average price we get from analysts is $2.50 which is $1.7 above current price. OGEN currently has a short float of 7.36% and public float of 25.69M with average trading volume of 1.28M shares.
OGEN Market Performance
OGEN stocks went up by 12.41% for the week, with the monthly jump of 13.65% and a quarterly performance of -6.67%, while its annual performance rate touched -64.01%. The simple moving average for the period of the last 20 days is 13.69% for OGEN stocks with the simple moving average of -32.34% for the last 200 days.
OGEN Stocks 9.71% Far from 50 Day Moving Average
After a stumble in the market that brought OGEN to its low price for the period of the last 52 weeks, Oragenics, Inc. was unable to take a rebound, for now settling with -85.37% of loss for the given period.
The stock volatility was left at 5.72%, however, within the period of a single month, the volatility rate increased by 5.66%, while the shares surge at the distance of +13.41% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by -3.17% lower at the present time.
In the course of the last 5 trading sessions, OGEN went up by +12.41%, which changed the moving average for the period of 200 days to the total of +30.24% of gains for the stock in comparison to the 20-day moving average settled at $0.48. In addition, Oragenics, Inc. saw -36.31% in overturn over the period of a single year with a tendency to cut further losses.
OGEN Stock Insider Trading
Reports are indicating that there were more than several insider trading activities at Oragenics, Inc. (OGEN), starting from KOSKI FAMILY LP, who bought 22,000 shares at the price of $0.41 back on Sep 18. After this action, Rushing now owns 277,839 shares of Oragenics, Inc., valued at $9,009 with the latest closing price.
KOSKI FAMILY LP, the 10% Owner of Oragenics, Inc., bought 100,000 shares at the value of $0.42 during a trade that took place back on Sep 17, which means that KOSKI FAMILY LP is holding 255,839 shares at the value of $42,000 based on the most recent closing price.
OGEN Stock Fundamentals
Based on Oragenics, Inc. (OGEN), the company’s capital structure generated 0.59 points for debt to equity in total, while total debt to capital is set at the value of 0.59.